BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Job Trends

  Orthofix to Present at Jefferies 2018 Global Healthcare Conference

  Orthofix International N.V. announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2018 Global Healthcare Conference.

  May 30, 2018

   · 

  1 min read
• Biotech Bay

  Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure

  – Funds Will Support Continued Clinical Evaluation of the AccuCinch Left Ventricular Repair System –

  May 30, 2018

   · 

  3 min read
• Business

  Nordic Nanovector: Rainer Boehm, MD Elected to Board of Directors

  Nordic Nanovector ASA (OSE: NANO) today announces that Rainer Boehm, MD was elected as a member of its Board of Directors at the company’s Annual General Meeting on 30 May 2018.

  May 30, 2018

   · 

  2 min read
• Pharm Country

  High Falls Extracts™ Launches New Product Line at the Cannabis World Congress

  High Falls Extracts, LLC has announced their business and product launch at this week’s Cannabis World Congress & Business Exposition (CWCBExpo) in New York City.

  May 30, 2018

   · 

  3 min read
• FDA

  FDA Broadens ClearGuard® HD Antimicrobial Barrier Cap Indications

  - ClearGuard HD Caps Have Been Shown to Reduce Central Line-Associated Bloodstream Infections in Hemodialysis Patients

  May 30, 2018

   · 

  2 min read
• Policy

  Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence

  Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and Braeburn announce that they have agreed to terminate the December 2012 license agreement, which granted Braeburn exclusive rights to commercialize Probuphine in the United States and Canada.

  May 30, 2018

   · 

  5 min read
• Biotech Bay

  KindredBio Announces Positive Results from Pilot Effectiveness Study of KIND-014 for the Treatment of Gastric Ulcers in Horses

  Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from its pilot field effectiveness study of KIND-014 for the treatment of gastric ulcers in horses.

  May 30, 2018

   · 

  1 min read
• Biotech Bay

  BioTime to Present at the 8th Annual LD Micro Invitational

  BioTime, Inc. announced that Russell Skibsted, Chief Financial Officer of BioTime, will be presenting at the 8th Annual LD Micro Invitational Conference.

  May 30, 2018

   · 

  2 min read
• Biotech Bay

  New Veeva Vault Training Provides Life Sciences a Modern Cloud Application for Effective Role-based Training

  Veeva Systems announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant.

  May 30, 2018

   · 

  4 min read
• Business

  CleanSlate Announces $25 Million Funding to Expand Opioid and Alcohol Addiction Treatment across the Nation

  CleanSlate has secured $25 million in a recent financing.

  May 30, 2018

   · 

  4 min read